Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Dracaena cinnabari
L'arbre emblématique de l'île de Socotra, arbre du dragon, avec son résin de sang de dragon utilisé en médecine traditionnelle de manière similaire à D. draco.
Dracaena cinnabari, commonly known as Dragon's Blood, is a tree endemic to Socotra whose red resin has been used traditionally for wound healing and antimicrobial purposes. Its primary active compounds include dracorhodin, flavonoids, and tannins, which contribute to its astringent, anti-inflammatory, and antimicrobial properties. Modern evidence is limited (Level C), supporting topical use for minor wounds and skin infections.
Dracorhodin, a major constituent, exhibits antimicrobial activity by disrupting bacterial cell membranes and inhibiting biofilm formation. Flavonoids and tannins provide astringent and anti-inflammatory effects through inhibition of cyclooxygenase (COX) and lipoxygenase (LOX) pathways, reducing prostaglandin and leukotriene synthesis. Additionally, the resin promotes wound healing by stimulating fibroblast proliferation and collagen deposition, possibly via activation of TGF-β signaling.
L'arbre emblématique de l'île de Socotra, arbre du dragon, avec son résin de sang de dragon utilisé en médecine traditionnelle de manière similaire à D. draco.
Dracaena cinnabari, commonly known as Dragon's Blood, is a tree endemic to Socotra whose red resin has been used traditionally for wound healing and antimicrobial purposes. Its primary active compounds include dracorhodin, flavonoids, and tannins, which contribute to its astringent, anti-inflammatory, and antimicrobial properties. Modern evidence is limited (Level C), supporting topical use for minor wounds and skin infections.
Dracorhodin, a major constituent, exhibits antimicrobial activity by disrupting bacterial cell membranes and inhibiting biofilm formation. Flavonoids and tannins provide astringent and anti-inflammatory effects through inhibition of cyclooxygenase (COX) and lipoxygenase (LOX) pathways, reducing prostaglandin and leukotriene synthesis. Additionally, the resin promotes wound healing by stimulating fibroblast proliferation and collagen deposition, possibly via activation of TGF-β signaling.